En Lai is a local principal in the Real Estate practice group of Baker & McKenzie Wong & Leow in Singapore. He regularly advises multi-national corporations (including pharmaceuticals, biopharmaceutical and medical devices companies) in the acquisition and divestment of real estate interests, the trustees and managers of various Singapore listed REITs, land developers and private equity funds in their asset acquisitions and divestments. En Lai has experience across a variety of corporate real estate transactions including the establishment of real estate investments trusts, sale and purchase of commercial, residential and industrial land and properties, joint ventures for property development in Singapore and advising on complex real estate matters relating to industrial properties owned by Jurong Town Corporation (JTC).
The global business community is more interconnected than ever, so clients value our integrated solutions and seamless advice as they deliver business objectives while mitigating risk. Get advice from the go-to firm for major Singapore companies, multinationals and financial institutions especially recognized for work on high-profile transactions across a wide range of industry groups and sectors.
Leverage broad global coverage and comprehensive local knowledge to effectively manage the challenges and opportunities of doing business in Singapore and the rest of Asia. Baker McKenzie Wong & Leow is a joint law venture between Baker McKenzie and Wong & Leow LLC, a Singapore law firm. This enables you to get the best advice on both domestic Singapore law issues and cross-border issues.
Gain access to a wider network that offers experts based on the ground across ASEAN countries as well as to Baker McKenzie’s wider international network. As counsel of choice to many companies using Singapore as a hub for their regional operations, our lawyers can help your business manage multi-jurisdictional transactions and mitigate cross-border risk.
For more information, please visit www.bakermckenzie.com.
Past Mingtiandi Events
Office Strategies Forum 2023 — Life Science and Core Office Investment in APAC